» Articles » PMID: 39050126

Hospital Outcomes of Acute COVID-19 Infection Among Patients with Neurological Conditions: a Single-center Study

Overview
Journal Front Neurol
Specialty Neurology
Date 2024 Jul 25
PMID 39050126
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronavirus disease 2019 (COVID-19) infection has been associated with severe neurological consequences, including stroke or seizures, and less severe neurological sequelae, including headaches, dizziness, and anosmia. Earlier COVID-19 variants were associated with high morbidity and mortality; however, knowledge of the impact of neurological conditions in the setting of COVID-19 on healthcare outcomes is limited. We sought to determine the impact of acute neurological conditions and acute COVID-19 infection on inpatient hospitalization outcomes.

Methods: This was a retrospective, observational study of adult patients who were admitted to a large academic medical center in the Southeastern US between April 2020 and December 2021 with acute COVID-19 infection and a neurological diagnosis. Patient demographics, medical history, neurological diagnoses, and hospitalization outcomes were obtained from the medical record. Descriptive statistics and unadjusted and adjusted logistic regression analyses were performed.

Results: Of the 1,387 patients included in this study, 27% died and 23% were kept under ventilation during hospitalization. The mean +/- standard deviation (SD) age was 64.6+/-16.9 years, with 52.8% women and 30.1% identifying as Black/African American. The most common neurological conditions included ischemic stroke (35.0%), movement disorder (12.0%), and hemorrhagic stroke (10.7%). In-hospital death was most common among those with epilepsy ( = 0.024), headache ( = 0.026), and dementia ( < 0.0001) compared to individuals without those conditions. Ventilation support was given more commonly to dementia patients ( = 0.020). Age was a significant risk factor for death ( < 0.001) and hospital length of stay (LOS) for ventilation ( < 0.001), but no neurological condition was a significant factor in adjusted logistic regression analyses.

Discussion: Mortality was high in this study, with more than one-quarter of patients dying in the hospital. Death was the most common among those with epilepsy, headache, or dementia, but no neurological condition increased the risk of in-hospital mortality or ventilation. Future studies would determine the long-term neurological sequelae of those discharged from the hospital with COVID-19 and a neurological condition.

References
1.
Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V . Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. 2020; 27(3):458-466. PMC: 7661948. DOI: 10.1016/j.cmi.2020.11.005. View

2.
Needham E, Ren A, Digby R, Norton E, Ebrahimi S, Outtrim J . Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain. 2022; 145(11):4097-4107. PMC: 9494359. DOI: 10.1093/brain/awac321. View

3.
Chou S, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V . Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021; 4(5):e2112131. PMC: 8114143. DOI: 10.1001/jamanetworkopen.2021.12131. View

4.
Bhola S, Trisal J, Thakur V, Kaur P, Kulshrestha S, Bhatia S . Neurological toll of COVID-19. Neurol Sci. 2022; 43(4):2171-2186. PMC: 8761097. DOI: 10.1007/s10072-022-05875-6. View

5.
Zhang P, He Z, Yao X, Tang R, Ma J, Luo T . COVID-19-associated monocytic encephalitis (CAME): histological and proteomic evidence from autopsy. Signal Transduct Target Ther. 2023; 8(1):24. PMC: 9816522. DOI: 10.1038/s41392-022-01291-6. View